MEDI-524
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for MEDI-524, covering 2008-07-28 to 2022-01-05. Get the full timeline:
Most recent: Clinical Trial Update: MEDI-524 (Motavizumab) for the Prevention of Respiratory Sycytial Virus (RSV) Disease Among Native American Indian Infants in the Southwestern United States [Phase 3]